MedPath

Edessy Stem Cell Score (ESS), Endometrium, Endometrioma

Not Applicable
Completed
Conditions
Endometriosis, Ovarian
Interventions
Procedure: Ovarian and endometrial samples
Registration Number
NCT02103452
Lead Sponsor
Al-Azhar University
Brief Summary

Purpose of this study is to evaluate stem cell expression (SCE) in endometriotic (E) and non endometriotic ovarian and endometrial tissues.

Detailed Description

This study was conducted on 40 women at Al-Azhar University Hospitals. They are divided into two equal groups, group 1 with ovarian endometrioma and group 2 with normal ovary. Ovarian and endometrial samples were evaluated by hematoxlin \& eosin for histopathology (HP) and of oct-4 for immunohistochemistry (IH) for SCE.

Evaluation of IH parameters revealed that the most important factors for evaluating SC were arranged as score ( Edessy Stem Cell Score=ESS).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • 20 to 40 years and did not receive hormonal treatment for three month
Exclusion Criteria
  • Diabetes mellitus, cardiovascular and kidney diseases, adenomyosis, Uterine fibroid Endometrial carcinoma and Poly cystic ovary

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ovarian endometriomaOvarian and endometrial samplesOvarian and endometrial samples
normal ovaryOvarian and endometrial samplesOvarian and endometrial samples
Primary Outcome Measures
NameTimeMethod
Edessy Stem Cell Score (ESS)1 week

ESS

* Intensity of stem cell marker: Negative to mild =0, Moderate =1, Strong =2

* Percentage of stained cells: 0 =0, 0-50%= 1, \>50-100% =2.

* Focality : None =0, Focal =1, Diffuse= 2

* Distribution: None= 0, Epithelial or mesenchymal= 1, Epithelial and mesenchymal= 2.

* Localization of positive stained cell: None=0, Cytoplasmic or nuclear =1, Cytoplasmic and nuclear= 2

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Al Azhar University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath